Medications

Antiviral drug molnupiravir linked to SARS-CoV-2 mutations

Researchers at the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the University of Cape Town and UKHSA have uncovered a link between an antiviral drug for COVID-19 ...

Diseases, Conditions, Syndromes

Researchers combat Zika-associated fetal abnormalities using microRNA

Before SARS-CoV-2 and COVID-19, there was the Zika virus epidemic, lasting from 2015 to 2016. The Zika virus can cause serious birth defects and abnormalities. During the epidemic, one of the most striking results of Zika ...

Diseases, Conditions, Syndromes

SARS-CoV-2, the virus behind COVID-19, can infect sensory neurons

When COVID-19 began spreading in 2020, some of its most common symptoms affected the peripheral nervous system, the network of nerves that enables communication between the brain and the rest of the body. Many people reported ...

Genetics

SARS-CoV-2: The grasping fingers of the viral N protein

Immediately after the infection of a cell in the throat or lungs, the SARS-CoV-2 virus works very hard to replicate, using the human cell's metabolic pathways to produce its proteins and make sure that its genetic material ...

Medical research

Study unveils picolinic acid's broad-spectrum antiviral abilities

Picolinic acid, a natural compound produced by mammalian cells, can block several disease-causing viruses such as SARS-CoV-2 and influenza A viruses, according to a new study by researchers at the Indian Institute of Science ...

page 5 from 40